According to a report by Global Times on April 19, the Board of Directors of the Brazilian National Health Surveillance Agency (Anvisa) will hold a meeting to discuss whether to maintain the ban on the sale of e-cigarettes in Brazil.
Since 2009, the Brazilian health regulatory agency has issued a resolution prohibiting the importation, sale, and advertisement of e-cigarette products. However, despite this, e-cigarettes are still easily found in popular stores or online, with sales remaining high. This is especially concerning as the consumption among young people continues to increase, posing serious health consequences.
In the process of reviewing current standards, the Brazilian National Health Surveillance Agency conducted a public consultation, which revealed that the majority of healthcare professionals expressed their opposition to the standard being implemented in Brazil. Considering the total number of participants, almost 59% of people indicated they support changing the current regulations. While the public consultation is not mandatory, the agency still decided to review the impact of the rule, taking into account recent research on e-cigarettes.
A heated debate has erupted on social media regarding whether to maintain the ban on the sale of e-cigarettes, against the backdrop of the tobacco industry supporting liberalization. During the consultation period, the industry launched the "I choose" campaign, posting paid articles on social media to encourage people to participate in the discussion and highlighting e-cigarettes as a "potentially less toxic alternative to cigarettes." The main argument of e-cigarette advocates is that unlike regular cigarettes that contain tobacco and release carcinogenic carbon monoxide, e-cigarettes vaporize and thus pose less harm. However, experts say the reality is different. E-cigarettes contain over two thousand substances, some of which are toxic and carcinogenic.
The Brazilian Tobacco Industry Association (Abifumo) believes that the current ban is not effective as products are still circulating. "We emphasize the urgency of regulation to establish clear and strict rules for marketing, prevent consumption by minors under 18, who should not have access to these products under any circumstances; in addition, the correct information about e-cigarettes should be provided to the public," he said in a statement issued after the public consultation results.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
